Avecho Biotechnology Ltd. engages in the development and commercialization of human and animal products through its proprietary drug delivery system. The company is headquartered in Melbourne, Victoria. The firm develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The firm's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The firm's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The firm is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.
Follow-Up Questions
AVEFF 주식의 가격 성능은 어떻습니까?
AVEFF의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Avecho Biotechnology Ltd의 주요 사업 주제나 업종은 무엇입니까?
Avecho Biotechnology Ltd은 Pharmaceuticals 업종에 속하며, 해당 부문은 Health Care입니다
